These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2654254)

  • 1. A double-blind, placebo-controlled, crossover trial of ketotifen versus hydroxyzine in the treatment of pediatric mastocytosis.
    Kettelhut BV; Berkebile C; Bradley D; Metcalfe DD
    J Allergy Clin Immunol; 1989 May; 83(5):866-70. PubMed ID: 2654254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of disodium cromoglycate and ketotifen on the excretion of histamine and N tau-methylimidazole acetic acid in urine of patients with mastocytosis.
    Mallet AI; Norris P; Rendell NB; Wong E; Greaves MW
    Br J Clin Pharmacol; 1989 Jan; 27(1):88-91. PubMed ID: 2495814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of systemic mastocytosis; therapeutic efficacy of ketotifen.
    Póvoa P; Ducla-Soares J; Fernandes A; Palma-Carlos AG
    J Intern Med; 1991 May; 229(5):475-7. PubMed ID: 2040876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term, placebo-controlled trial of ketotifen in the management of preschool children with asthma.
    Loftus BG; Price JF
    J Allergy Clin Immunol; 1987 Feb; 79(2):350-5. PubMed ID: 3546465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of ketotifen in young children with asthma.
    Volovitz B; Varsano I; Cumella JC; Jaber L
    J Allergy Clin Immunol; 1988 Mar; 81(3):526-30. PubMed ID: 3279095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of mediator release in systemic mastocytosis is associated with reversal of bone changes.
    Graves L; Stechschulte DJ; Morris DC; Lukert BP
    J Bone Miner Res; 1990 Nov; 5(11):1113-9. PubMed ID: 2270775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Canadian multicenter study with Zaditen (ketotifen) in the treatment of bronchial asthma in children aged 5 to 17 years.
    Rackham A; Brown CA; Chandra RK; Ho P; Hoogerwerf PE; Kennedy RJ; Knight A; Langer H; Milne J; Moote DW
    J Allergy Clin Immunol; 1989 Sep; 84(3):286-96. PubMed ID: 2674262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of azelastine and chlorpheniramine in the treatment of mastocytosis.
    Friedman BS; Santiago ML; Berkebile C; Metcalfe DD
    J Allergy Clin Immunol; 1993 Oct; 92(4):520-6. PubMed ID: 8104966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of acrivastine versus hydroxyzine and placebo in the treatment of chronic idiopathic urticaria.
    Salo OP; Harvey SG; Calthrop JG; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():18B-21B. PubMed ID: 2569996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled multiphase trial of ketotifen to minimize neurofibroma-associated pain and itching.
    Riccardi VM
    Arch Dermatol; 1993 May; 129(5):577-81. PubMed ID: 8481017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H1-antihistamines for primary mast cell activation syndromes: a systematic review.
    Nurmatov UB; Rhatigan E; Simons FE; Sheikh A
    Allergy; 2015 Sep; 70(9):1052-61. PubMed ID: 26095756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketotifen for asthma in children aged 5 to 15 years: a randomized placebo-controlled trial.
    Kabra SK; Pandey RM; Singh R; Seth V
    Ann Allergy Asthma Immunol; 2000 Jul; 85(1):46-52. PubMed ID: 10923604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary randomised double-blind placebo-controlled clinical trial of hydroxyzine for treating sleep bruxism in children.
    Ghanizadeh A; Zare S
    J Oral Rehabil; 2013 Jun; 40(6):413-7. PubMed ID: 23550945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicentre randomized placebo-controlled double-blind study on the efficacy of Ketotifen in infants with chronic cough or wheeze.
    van Asperen PP; McKay KO; Mellis CM; Loh RK; Harth SC; Thong YH; Harris M; Robertson IF; Gibbeson M; Rhodes L
    J Paediatr Child Health; 1992 Dec; 28(6):442-6. PubMed ID: 1466940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Zaditen (ketotifen) in wheezy infants and young children.
    Chay OM; Foo AL; Ho L
    J Singapore Paediatr Soc; 1992; 34(3-4):235-9. PubMed ID: 1305670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic mastocytosis].
    Sade K; Dotan I; Levo Y
    Harefuah; 2000 Sep; 139(5-6):202-6, 245. PubMed ID: 11062953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of recurrent wheezing in young children by loratadine compared with ketotifen.
    Ngamphaiboon J; Wirawarn T; Thongkaew T
    J Med Assoc Thai; 2009 Mar; 92(3):351-5. PubMed ID: 19301727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of systemic mastocytosis with flushing, palpitation and dyspnea].
    Kawano Y; Abe H; Yoshida K; Saitoh F; Kuramochi M; Ito K; Omae T
    Nihon Naika Gakkai Zasshi; 1987 Dec; 76(12):1883-4. PubMed ID: 3450776
    [No Abstract]   [Full Text] [Related]  

  • 19. Ketotifen: a new drug for prophylaxis of asthma in children.
    Simons FE; Luciuk GH; Becker AB; Gillespie CA
    Ann Allergy; 1982 Mar; 48(3):145-50. PubMed ID: 6121527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of ketotifen in a controlled double-blind food challenge study in patients with food allergy.
    Boner AL; Richelli C; Antolini I; Vibelli C; Andri L
    Ann Allergy; 1986 Jul; 57(1):61-4. PubMed ID: 3524320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.